SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 31, Pages eabh3409
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-07-31
DOI
10.1126/sciadv.abh3409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Neutralizing antibody titres in SARS-CoV-2 infections
- (2021) Eric H. Y. Lau et al. Nature Communications
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
- (2020) Qing Lei et al. ALLERGY
- Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
- (2020) Saki Takahashi et al. JOURNAL OF INFECTIOUS DISEASES
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- (2020) Mark Ainsworth et al. LANCET INFECTIOUS DISEASES
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
- (2020) Ekasit Kowitdamrong et al. PLoS One
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco
- (2020) Genay Pilarowski et al. JOURNAL OF INFECTIOUS DISEASES
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- (2011) M. Herdman et al. QUALITY OF LIFE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started